Compare Heron Therapeutics Inc (HRTX) vs iShares Core S&P 500 ETF (IVV) Price & Performance

Heron Therapeutics IncTrade

iShares Core S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs iShares Core S&P 500 ETF — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while iShares Core S&P 500 ETF trades at $776.06. The key difference: iShares Core S&P 500 ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

	HRTX	IVV
Market Cap	$61.47M	—
Sector	Health	Broad Market / Factor
52-Week High	$1.49	$776.81
52-Week Low	$0.32	$634.93
Enterprise Value	$168.21M	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HRTX

Heron Therapeutics misses Q2 earnings and revenue estimates, pauses sales expansion, withdraws full-year outlook.Alex Lavoie · 1 day agoBearish View details →

IVV

WisdomTree U.S. Total Dividend ETF (DTD) rated 'hold' for balanced factors but overlaps 57% with S&P 500 ETFs.Seeking Alpha · 1 day agoNeutral Main Sector Rotation ETF (SECT) gets Hold rating due to weak performance versus IVV.Seeking Alpha · 4 days agoNeutral View details →

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

About iShares Core S&P 500 ETF

IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.